Clin2
NCT07766122Possibly a fitNot yet recruiting

PSMA PET scans before HIFU for prostate cancer

Prostate Cancer - RecurrentProstate Cancer (Diagnosis)

Part of Cancer, Kidney & urinary clinical trials.

This trial tests whether a special scan called a PSMA PET scan can help doctors better plan treatment with high-intensity focused ultrasound (HIFU) for prostate cancer. If successful, it may help target the cancer more precisely and reduce side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
30 people
Ages
70 years and older
Study type
Interventional

Who can take part

  • You have prostate cancer.
  • You are 70 years or older.
  • Your doctor expects you to live more than 5 more years.
  • The cancer is at an early stage and low to intermediate risk (PSA less than 20, ISUP grade 2 on one side of the prostate or less).
  • You have a single suspicious lesion on MRI (PIRADS 3, 4, or 5) and a prostate volume under 150 ml.
  • You are not currently on any other treatment for prostate cancer (based on the trial's focus on HIFU).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07115914Recruiting
PSMA PET scan to monitor prostate cancer after focal therapy

This trial uses a special PET scan (PSMA PET) to check if prostate cancer returns after focused treatment (focal therapy). It may help find any remaining cancer that standard scans miss.

Chicago, Illinois
NCT07184970Recruiting
Detecting prostate cancer return after HIFU with advanced scans

This trial uses a special PET/MRI scan to check if prostate cancer has come back after high-intensity focused ultrasound (HIFU) treatment. It aims to find any remaining cancer early so doctors can plan next steps.

New York, New York
NCT05520255Recruiting· Phase 3
PSMA PET/CT scan to guide care after prostate cancer treatment

This Phase 3 study checks whether a PSMA PET/CT scan (using a special tracer) can help doctors make better decisions for people with prostate cancer after treatment, based on PSA blood test changes. It may help identify whether cancer has spread or how to plan next steps.

Edmonton, Alberta
NCT06122584Recruiting· Phase 3
PSMA PET scan for high-risk prostate cancer before surgery

This trial tests if a special PET scan using PSMA-1007 can find prostate cancer spread in men who have just been diagnosed with high-risk prostate cancer and plan to have surgery. The scan may help doctors better understand the cancer before removing the prostate and lymph nodes.

Nancy
NCT03327675Recruiting
PET imaging test to plan personalized prostate cancer treatment

This trial tests a high-precision scan that uses a prostate cancer marker to show where cancer may be. The goal is to use the scan results to better plan treatment, especially around surgery and lymph nodes, in certain patients with prostate cancer.

Leuven
NCT04402151Recruiting· Phase 2
PSMA scan–guided targeted radiation for higher-risk prostate cancer

This trial uses a special PET/MR scan to help doctors aim stereotactic radiation more precisely for certain higher-risk or unfavorable intermediate prostate cancers. It studies whether this targeted approach can safely treat the prostate (and specific areas needing extra treatment) without spreading to the body.

New York, New York

Hear when a new Prostate Cancer Recurrent trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.